Nox Health

Canaccord Genuity Acts as Exclusive Financial Advisor to Nox Health on its Strategic Investment from Vestar Capital Partners

Canaccord Genuity is pleased to announce that it advised Nox Health Group, Inc., an Atlanta and Icelandic-based provider of sleep health solutions, who offers a comprehensive, tech-enabled sleep platform that supports patients across the care continuum, on its strategic investment from Vestar Capital Partners, a growth-oriented private equity firm based in New York.

Nox Health is a global sleep health leader, committed to people-centered solutions that address the worldwide sleep epidemic and promote access to sleep healthcare for long-term treatment and support. Nox Health was formed with the fundamental understanding that sleep is a necessity of life and critical to healthy and productive individuals. The Company works with its partners — employers, health systems, health plans, government health programs, and primary care and specialty provider groups — to bring effective sleep solutions to patient populations.

Nox Health eliminates the common pain points associated with sleep testing and delivers unparalleled data quality and insights for clinicians. Further, the Company’s SleepCharge program, for employers and health plans, gives people easy access to medical and behavioral care for sleep that delivers long-term success.

Together, Nox and Vestar are positioned to deliver sleep solutions to a broader base of customers and patients and accelerate the Company’s growth. The investment will help Nox accelerate development of its sleep diagnostic technology and services and adoption of its value-based comprehensive sleep management solutions for employers and health plans. 

Canaccord Genuity, with a team led by Dudley Baker and Fred Fang, served as the exclusive financial advisor to Nox Health.